Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine
2. Lu Ae58054
3. Lu-ae58054
4. Luae58054
1. 467459-31-0
2. Lu Ae58054
3. Lu-ae58054
4. 2-(6-fluoro-1h-indol-3-yl)-n-[[3-(2,2,3,3-tetrafluoropropoxy)phenyl]methyl]ethanamine
5. Lu Ae 58054
6. 1h-indole-3-ethanamine, 6-fluoro-n-[[3-(2,2,3,3-tetrafluoropropoxy)phenyl]methyl]-
7. 59wcj0ynwm
8. Sgs518
9. Lu Ae-58054
10. Lu-ae-58054
11. Ly483518
12. Ly-483518
13. 2-(6-fluoro-1h-indol-3-yl)-n-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)ethan-1-amine
14. N-(2-(6-fluoro-1h-indol-3-yl)ethyl)-3-(2,2,3,3-tetrafluoropropoxy)benzylamine
15. Unii-59wcj0ynwm
16. Idalopirdine [usan:inn]
17. Idlopirdine
18. 1h-indole-3-ethanamine, 6-fluoro-n-((3-(2,2,3,3-tetrafluoropropoxy)phenyl)methyl)-
19. Idalopirdine [usan]
20. Idalopirdine (usan/inn)
21. Idalopirdine [inn]
22. Lu Ae58054;idalopirdine
23. Idalopirdine [who-dd]
24. Schembl762762
25. Gtpl8689
26. Idalopirdine(lu-ae-58054)
27. Chembl3286580
28. Ex-a844
29. Dtxsid201026015
30. Bcp08339
31. Bdbm50019754
32. Mfcd18633269
33. Zinc95936819
34. Akos028114439
35. Cs-1347
36. Db11957
37. Sb16535
38. Ncgc00378842-04
39. Ac-30941
40. Da-21188
41. Hy-14338
42. Ft-0700312
43. D10710
44. Q855545
45. N-[3-(2,2,3,3-tetrafluoropropoxy)benzyl]-6-fluoro-1h-indole-3-ethanamine
46. 1h-indole-3-ethanamine,6-fluoro-n-[[3-(2,2,3,3-tetrafluoropropoxy)phenyl]methyl]-
Molecular Weight | 398.4 g/mol |
---|---|
Molecular Formula | C20H19F5N2O |
XLogP3 | 5 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 9 |
Exact Mass | 398.14175404 g/mol |
Monoisotopic Mass | 398.14175404 g/mol |
Topological Polar Surface Area | 37 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 482 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in neurologic disorders and schizophrenia and schizoaffective disorders.
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
SGS518 is a selective antagonist of the 5-Hydroxytryptamine-6 (5-HT6) serotonin receptor believed to act by enhancing transmission of chemicals in the brain.
ABOUT THIS PAGE
A Idalopirdine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Idalopirdine, including repackagers and relabelers. The FDA regulates Idalopirdine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Idalopirdine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Idalopirdine supplier is an individual or a company that provides Idalopirdine active pharmaceutical ingredient (API) or Idalopirdine finished formulations upon request. The Idalopirdine suppliers may include Idalopirdine API manufacturers, exporters, distributors and traders.
Idalopirdine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Idalopirdine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Idalopirdine GMP manufacturer or Idalopirdine GMP API supplier for your needs.
A Idalopirdine CoA (Certificate of Analysis) is a formal document that attests to Idalopirdine's compliance with Idalopirdine specifications and serves as a tool for batch-level quality control.
Idalopirdine CoA mostly includes findings from lab analyses of a specific batch. For each Idalopirdine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Idalopirdine may be tested according to a variety of international standards, such as European Pharmacopoeia (Idalopirdine EP), Idalopirdine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Idalopirdine USP).
LOOKING FOR A SUPPLIER?